A PHASE IB/IIB, OPEN-LABEL, MULTI-CENTER, STUDY OF ORAL PANOBINOSTAT ADMINISTERED WITH 5-AZACITIDINE (IN ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), OR ACUTE MYELOID LEUKEMIA (AML).: